EDGAR Filing Documents for 0001047469-16-010780

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-16-010780

Filing Date

2016-03-04

Accepted

2016-03-04 16:14:17

Documents

Period of Report

2015-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2227601z10-k.htm	10-K	1226690
2	EX-23.1	a2227601zex-23_1.htm	EX-23.1	3230
3	EX-23.2	a2227601zex-23_2.htm	EX-23.2	2820
4	EX-31.1	a2227601zex-31_1.htm	EX-31.1	7999
5	EX-31.2	a2227601zex-31_2.htm	EX-31.2	8103
6	EX-32.1	a2227601zex-32_1.htm	EX-32.1	4815
7	EX-32.2	a2227601zex-32_2.htm	EX-32.2	4834
14	G708537.JPG	g708537.jpg	GRAPHIC	40030
	Complete submission text file	0001047469-16-010780.txt		6719711

Data Files

Seq	Description	Document	Type	Size
8	EX-101.INS	nviv-20151231.xml	EX-101.INS	1495147
9	EX-101.SCH	nviv-20151231.xsd	EX-101.SCH	58347
10	EX-101.CAL	nviv-20151231_cal.xml	EX-101.CAL	51125
11	EX-101.LAB	nviv-20151231_lab.xml	EX-101.LAB	551147
12	EX-101.PRE	nviv-20151231_pre.xml	EX-101.PRE	393882
13	EX-101.DEF	nviv-20151231_def.xml	EX-101.DEF	185833

Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524

INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)